Digallic acid - Compound Card

Digallic acid

Select a section from the left sidebar

Digallic acid

Structure
Zoomed Structure
  • Family: Plantae - Anacardiaceae
  • Kingdom: Plantae
  • Class: Phenolic
Canonical Smiles OC(=O)c1cc(O)c(c(c1c1c(cc(c(c1O)O)O)C(=O)O)O)O
InChI InChI=1S/C14H10O10/c15-5-1-3(13(21)22)7(11(19)9(5)17)8-4(14(23)24)2-6(16)10(18)12(8)20/h1-2,15-20H,(H,21,22)(H,23,24)
InChIKey MFTSECOLKFLUSD-UHFFFAOYSA-N
Formula C14H10O10
HBA 8
HBD 8
MW 338.22
Rotatable Bonds 3
TPSA 195.98
LogP 0.98
Number Rings 2
Number Aromatic Rings 2
Heavy Atom Count 24
Formal Charge 0
Fraction CSP3 0.0
Exact Mass 338.03
Number of Lipinski Rule Violations 1
# Species Family Kingdom NCBI Taxonomy ID
1 Pistascia lentiscus Anacardiaceae Plantae

Showing of synonyms

  • Bhouri W, Skandrani I, et al. (2012). Digallic acid from Pistascia lentiscus fruits induces apoptosis and enhances antioxidant activities. Phytotherapy Research,2012,26(3),387-391. [View] [PubMed]
Pubchem: 341
Kegg Ligand: C01572
Chebi: 30814
Nmrshiftdb2: 60028386
Bindingdb: 50056937
CPRiL: 209753
Structure

SMILES: c1ccccc1-c2ccccc2

Level: 1

Mol. Weight: 338.22 g/mol

Structure

SMILES: c1ccccc1

Level: 0

Mol. Weight: 338.22 g/mol

Antioxidant
Antiproliferative
Apoptotic properties

Absorption

Caco-2 (logPapp)
-6.27
Human Oral Bioavailability 20%
Non-Bioavailable
Human Intestinal Absorption
Non-Absorbed
Madin-Darby Canine Kidney
-6.38
Human Oral Bioavailability 50%
Non-Bioavailable
P-Glycoprotein Inhibitor
Non-Inhibitor
P-Glycoprotein Substrate
Non-Substrate
Skin Permeability
-1.64

Distribution

Blood-Brain Barrier (CNS)
-
Blood-Brain Barrier
Non-Penetrable
Fraction Unbound (Human)
0.73
Plasma Protein Binding
64.87
Steady State Volume of Distribution
-

Metabolism

Breast Cancer Resistance Protein
Non-Inhibitor
CYP 1A2 Inhibitor
Non-Inhibitor
CYP 1A2 Substrate
Non-Substrate
CYP 2C19 Inhibitor
Non-Inhibitor
CYP 2C19 Substrate
Non-Substrate
CYP 2C9 Inhibitor
Non-Inhibitor
CYP 2C9 Substrate
Non-Substrate
CYP 2D6 Inhibitor
Non-Inhibitor
CYP 2D6 Substrate
Non-Substrate
CYP 3A4 Inhibitor
Non-Inhibitor
CYP 3A4 Substrate
Non-Substrate
OATP1B1
Non-Inhibitor
OATP1B3
Non-Inhibitor

Excretion

Clearance
7.67
Organic Cation Transporter 2
Non-Inhibitor
Half-Life of Drug
-

Toxicity

AMES Mutagenesis
Safe
Avian
Safe
Bee
Safe
Bioconcentration Factor
-1.04
Biodegradation
Toxic
Carcinogenesis
Safe
Crustacean
Safe
Liver Injury I (DILI)
Safe
Eye Corrosion
Safe
Eye Irritation
Safe
Maximum Tolerated Dose
0.61
Liver Injury II
Toxic
hERG Blockers
Safe
Daphnia Maga
3.64
Micronucleos
Toxic
NR-AhR
Safe
NR-AR
Safe
NR-AR-LBD
Safe
NR-Aromatase
Safe
NR-ER
Safe
NR-ER-LBD
Safe
NR-GR
Safe
NR-PPAR-gamma
Safe
NR-TR
Safe
T. Pyriformis
4.03
Rat (Acute)
1.93
Rat (Chronic Oral)
4.35
Fathead Minnow
2.92
Respiratory Disease
Toxic
Skin Sensitisation
Safe
SR-ARE
Safe
SR-ATAD5
Safe
SR-HSE
Safe
SR-MMP
Safe
SR-p53
Safe

General Properties

Boiling Point
552.02
Hydration Free Energy
-9.09
Log(D) at pH=7.4
-3.45
Log(P)
1.92
Log S
-1.52
Log(Vapor Pressure)
-12.08
Melting Point
261.63
pKa Acid
5.63
pKa Basic
7.63
Protein Name UniProt ID Entry Name Species #Pharmacophore Points Probability (0.7 ≤ Tversky Score ≤ 1.0)
Serpin domain-containing protein H0ZQY2 H0ZQY2_TAEGU Taeniopygia guttata 3 0.9207
Serpin domain-containing protein H0ZQY2 H0ZQY2_TAEGU Taeniopygia guttata 3 0.9207
Glycogen synthase kinase-3 beta P49841 GSK3B_HUMAN Homo sapiens 3 0.7462
Glycogen synthase kinase-3 beta P49841 GSK3B_HUMAN Homo sapiens 3 0.7462
Polymerase acidic protein Q5EP34 Q5EP34_9INFA Influenza A virus 3 0.7434
Polymerase acidic protein Q5EP34 Q5EP34_9INFA Influenza A virus 3 0.7434
Uracil phosphoribosyltransferase Q26998 UPP_TOXGO Toxoplasma gondii 3 0.7130
Uracil phosphoribosyltransferase Q26998 UPP_TOXGO Toxoplasma gondii 3 0.7130

Download SDF